{"SPADE_UN_11886": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11886", "Peptide Name": "KR-12-a3 (Derived from KR-12)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "KRIVKRIKKWLR", "Sequence Length": 12, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.24105706] Gram-positive bacteria :Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);Gram-negative bacteria :Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)", "Hemolytic Activity": "[Ref.24105706] HC50>800 μM against human red blood cells", "Cytotoxicity": "[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 104.7%, 111.6%, 105.3%, 108.4%, 111.2%, 104.4%, 108.8% and 95.0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .", "Formula": "C76H138N26O13", "Mass": 1624.08, "PI": 12.0, "Net Charge": 7, "Hydrophobicity": -1.08, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria", "Literature": [{"Title": "Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.", "Pubmed ID": "24105706", "Reference": "J Pept Sci. 2013 Nov;19(11)700-7. doi 10.1002/psc.2552.", "Author": "Jacob B, Park IS, Bang JK, Shin SY", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=24105706"}, {"Title": "Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity", "Pubmed ID": "", "Author": "Jacob B, Park IS, Bang JK, Shin SY"}], "Frequent Amino Acids": "KRI", "Absent Amino Acids": "ACDEFGHMNOPQSTUY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 8, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04256", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRIV"}, {"SPADE_ID": "SPADE_N_04258", "Similarity": 1.0, "Sequence": "EFKRIV"}, {"SPADE_ID": "SPADE_N_05467", "Similarity": 1.0, "Sequence": "ILGKFCDEIKRIV"}]}}}